发明名称 Identifying calcineurin activators for treatment of schizophrenia
摘要 The present invention provides targets, methods, and reagents for the diagnosis and treatment of schizophrenia and related conditions. The invention provides methods for the diagnosis of schizophrenia and susceptibility to schizophrenia by detection of polymorphisms, mutations, variations, alterations in expression, etc., in calcineurin genes or calcineurin interacting genes, or polymorphisms linked to such genes. The invention provides oligonucleotides, arrays, and antibodies for detection of polymorphisms and variants. The invention provides transgenic mice having alterations in such genes. The invention also provides methods of treating schizophrenia by administering compounds that target these genes. The invention further provides screening methods for identifying such compounds and compounds obtained by performing the screens.
申请公布号 US7935500(B2) 申请公布日期 2011.05.03
申请号 US20030400348 申请日期 2003.03.26
申请人 MASSACHUSETTS INSTITUTE OF TECHNOLOGY;ROCKEFELLER UNIVERSITY 发明人 GERBER DAVID J.;KARAYIORGOU MARIA;MIYAKAWA TSUYOSHI;TONEGAWA SUSUMU
分类号 C12Q1/34;C12Q1/02;C12Q1/68;G01N33/15;G01N33/53 主分类号 C12Q1/34
代理机构 代理人
主权项
地址